Stephen Benoit

Stephen Benoit has an extensive work experience spanning over several decades. Stephen began their career in the US Navy as a Petty Officer 2nd Class from 1978 to 1984. Stephen then joined UMass Chan Medical School as a Research Associate in 1988 and worked there until 2000. At UMass Chan, they provided flow cytometry and cell sorting services, developed and standardized methods for studying platelet biology, and trained lab personnel.

In 2000, they joined Curis as a Researcher for two years. There, they established and managed a flow cytometry facility supporting various groups. Stephen coordinated instrument use, developed staining techniques, and evaluated new technologies to enhance the facility's capacity.

From 2002 to 2023, they worked at Pfizer as a Principal Scientist. During this time, they played a significant role in creating discovery projects targeting ectopic germinal center activity in RA patients. Stephen demonstrated T cell anergy and exhaustion as preclinical endpoints for tolerance induction projects. In collaboration with UMass Med Ctr, they developed an extensive immunophenotyping process for biomarker discovery in a study on Crohn's and ulcerative colitis patients.

Recently, Stephen has joined Cue Biopharma in 2023 as a Sr. Scientist - Pharmacology, and their role is ongoing.

Stephen Benoit obtained a Master of Business Administration (MBA) degree in Business Administration and Management, General, from Anna Maria College. Stephen attended Anna Maria College from 1998 to 2000. Prior to that, they completed a Bachelor of Science (BS) degree in Biochemistry from the University of Massachusetts Amherst, where they studied from 1984 to 1988. Additionally, Stephen Benoit has a certification as a Specialist in Cytometry SCYM (ASCP) CM, which was obtained in June 2017 from the American Society for Clinical Pathology (ASCP).